Chao Li

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Peritoneal Dialysis

Chronic Lymphocytic Leukemia

Top Venues

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Chao Li, ChengXin Deng, Ping Wu, KaiFan Liu, Xin Huang, MingMin Li, XiaoMei Chen, SuXia Geng, PeiLong Lai, Jian-Yu Weng, Xin Du
Outcomes of intermediate or high-risk CMML patients treated with hypomethylating agents combined with venetoclax: A single center experience. Clinical and translational science 17 (1) (2024)
Chao Li, ChengXin Deng, Ping Wu, KaiFan Liu, Xin Huang, MingMin Li, XiaoMei Chen, SuXia Geng, PeiLong Lai, Jian-Yu Weng, Xin Du
Outcomes of intermediate or high-risk CMML patients treated with hypomethylating agents combined with venetoclax: A single center experience. Clinical and translational science 17 (1) (2024)
Chao Li, ChengXin Deng, Ping Wu, KaiFan Liu, Xin Huang, MingMin Li, XiaoMei Chen, SuXia Geng, PeiLong Lai, Jian-Yu Weng, Xin Du
Outcomes of intermediate or high-risk CMML patients treated with HMAs combined with Venetoclax: a single center experience. Clinical and translational science (2023)
Chao Li, ChengXin Deng, Ping Wu, KaiFan Liu, Xin Huang, MingMin Li, XiaoMei Chen, SuXia Geng, PeiLong Lai, Jian-Yu Weng, Xin Du
Outcomes of intermediate or high-risk CMML patients treated with HMAs combined with Venetoclax: a single center experience. Clinical and translational science (2023)
Chao Li, ChengXin Deng, Ping Wu, KaiFan Liu, Xin Huang, MingMin Li, XiaoMei Chen, SuXia Geng, PeiLong Lai, Jian-Yu Weng, Xin Du
Outcomes of intermediate or high-risk CMML patients treated with HMAs combined with Venetoclax: a single center experience. Clinical and translational science (2023)